DDB1 and bladder transitional cell carcinoma: Taken together, these GSEA results highlight the significant role that DDB1 may play in regulating a spectrum of important biological processes associated with BLCA, and underscore its potential as a therapeutic target and biomarker for disease progression and prognosis.